Advisor Group, Inc. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 32 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$5,000
-44.4%
1,000
-66.7%
0.00%
Q3 2019$9,000
+125.0%
3,000
+200.0%
0.00%
Q2 2019$4,0000.0%1,0000.0%0.00%
Q1 2019$4,000
+33.3%
1,0000.0%0.00%
Q4 2018$3,000
-40.0%
1,0000.0%0.00%
Q3 2018$5,000
-28.6%
1,0000.0%0.00%
Q2 2018$7,0001,0000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders